Kirk, A. M., Crawford, J. C., Chou, C., Guy, C., Pandey, K., Kozlik, T., . . . Thomas, P. G. (2024). DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. Cell Reports Medicine, 5(3), . https://doi.org/10.1016/j.xcrm.2024.101469

Kirk, Allison M., et al. "DNAJB1-PRKACA Fusion Neoantigens Elicit Rare Endogenous T Cell Responses That Potentiate Cell Therapy for Fibrolamellar Carcinoma." Cell Reports Medicine 5, no. 3 (2024). https://doi.org/10.1016/j.xcrm.2024.101469.

Kirk, Allison M., et al. "DNAJB1-PRKACA Fusion Neoantigens Elicit Rare Endogenous T Cell Responses That Potentiate Cell Therapy for Fibrolamellar Carcinoma." Cell Reports Medicine, vol. 5, no. 3, 2024, https://doi.org/10.1016/j.xcrm.2024.101469.